OneSource gets Saudi nod for Ozempic generic, partner Hikma will commercialise
OneSource gets Saudi nod for generic-semaglutide-injection-for-weight-loss-diabetes-after-zempic-s-patent-expiry'>Ozempic generic, partner Hikma will commercialise is drawing significant interest across the industry.
The approval by the Saudi Food and Drug Authority paves the way for commercialization through its exclusive regional partner Hikma Pharmaceuticals Plc, the largest drugmaker in the Middle East and North Africa by sales.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Zerocam 2.0 for Android adds color profiles, lens support
- The D-II basketball finals are here. Here's what you need to know.
- Some of the Most Iconic, Hilarious, and Downright Questionable Aliases in Rock Music
- Pentagon Pete Can’t Stop Posting Cringe Workouts Videos
Source: Original →